T

Turn Biotechnologies

33 employees

Turn Biotechnologies is combating the effects of aging in the epigenome by repairing tissue at the cellular level with mRNA therapies.

Basic info

Industry

biotechnology research

Sectors

Cellular Programming
Biotechnology
Aging
Life Science
SCNT
osteoarthritis
Health Care
R&D
Cell Reprogramming
Therapeutics
Research and Development
Dermatology
ophthalmology
mRNA
Genetics

Date founded

2018

Funding rounds raised

T

Turn Biotechnologies raised undisclosed on April 11, 2022

Investors: Khosla Ventures, Shanda Group, ThreeD Capital Inc., Formic Ventures, Astellas Venture Capital L.L.C., LongeVC, HanAll BioPharma Co., Ltd and Methuselah Fund

T

Turn Biotechnologies raised undisclosed on April 28, 2021

Investors: Formic Ventures, Khosla Ventures and Shanda Group

T

Turn Biotechnologies raised undisclosed on August 26, 2019

Investors: Formic Ventures

T

Turn Biotechnologies raised undisclosed on June 6, 2019

Investors: KIZOO

FAQ